Tecan, Innovatis Ink Co-marketing Plan | GenomeWeb

NEW YORK (GenomeWeb News) – Tecan said today that it will collaborate with Innovatis to jointly market robotic cell culture workstations and cell detection devices.

Under the agreement, the companies will co-market Innovatis' Cellavista automated image-based cellular analysis platform and Tecan's Freedom EVO platform. Used together, Tecan said, the platforms allow automation of a wide range of cell-related processes including cell line development, cell proliferation, stem cell differentiation, and cell-based assays.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: weighting scheme increases GWAS power, and more.

Marc Tessier-Lavigne is to be the next president of Stanford University.

Walgreens has given Theranos 30 days to fix its lab issues, the Wall Street Journal reports.

Journals and research funding agencies pledge to enable the sharing of Zika virus research.